Image – Interventional flashlight

DOI: 10.4244/EIJ-D-18-00144

Coronary vasospastic angina: a rare case of ergonovine positivity and curative bilateral cardiac sympathectomy

Raman Sharma*, MD; Samin Sharma, MD; Valentin Fuster, MD, PhD

Figure 1. Coronary angiogram demonstrating vasospasm provocation by ergonovine. Red arrow: proximal left anterior descending artery. Blue arrow: proximal left circumflex artery. Yellow arrow: distal left circumflex artery

A 49-year-old female presented to the emergency room with resting chest pain. She carried a history of CAD, initially diagnosed in 2012, as well as dysautonomia and coronary vasospasm. Over the past five years, she has seen several cardiologists and has undergone over 10 catheterisations and four stent implantations. Despite these prior coronary interventions, she continued to be symptomatic with chest pain, at times even at rest, and a recent catheterisation revealed patent intervention sites with only a 60% ostial distal left circumflex artery stenosis. Treatment with beta-blockers and calcium channel blockers was attempted unsuccessfully as they were poorly tolerated and resulted in hypotension associated with her dysautonomia.

The current presentation was similar to prior acute coronary syndromes (ACS), where she had ST-elevation myocardial infarction (STEMI) at rest, which resolved spontaneously as she became chest pain free. The decision was made to perform left heart catheterisation with intracoronary ergonovine infusion, which resulted in 50% stenosis of the proximal left anterior descending artery, 50% stenosis of the proximal left circumflex and total occlusion of the distal left circumflex, associated with ST-elevations on ECG (Figure 1A, Figure 1B, Moving image 1-Moving image 6). Intracoronary nitroglycerine and verapamil resulted in complete reversal of vasospasm (Figure 1C, Moving image 7). Given refractoriness, the decision was made to pursue cardiac sympathectomy, which was accomplished through ablative therapy to the T5 ganglion to the lower half of the stellate ganglion, bilaterally. Postoperatively, the patient had an uncomplicated recovery, besides pain at the surgical site. Upon follow-up, her only complaint was atypical chest pain, probably related to the surgery, without ECGs demonstrating ischaemia. A repeat catheterisation also showed no response to ergonovine (Figure 1D, Moving image 8, Moving image 9).

Coronary vasospastic angina remains a difficult entity to treat1. Bilateral cardiac sympathectomy may be considered in patients with refractory coronary vasospasm2.

Conflict of interest statement

S. Sharma declares financial disclosures for the speaker’s bureau of Abbott, Boston Scientific, and Cardiovascular Systems, Inc. The other authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Pre-ergonovine RAO caudal.

Moving image 2. Pre-ergonovine RAO cranial.

Moving image 3. Pre-ergonovine LAO cranial.

Moving image 4. Ergonovine provocation RAO caudal.

Moving image 5. Ergonovine provocation RAO cranial.

Moving image 6. Ergonovine provocation LAO cranial.

Moving image 7. IC nitro and verapamil RAO caudal.

Moving image 8. 3-month follow-up ergonovine provocation RAO caudal.

Moving image 9. 3-month follow-up ergonovine provocation LAO cranial.

Volume 14 Number 12
Dec 20, 2018
Volume 14 Number 12
View full issue


Key metrics

On the same subject

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free

Clinical Research

10.4244/EIJ-D-21-00875 Aug 5, 2022
Features of atherosclerosis in patients with angina and no obstructive coronary artery disease
Pellegrini D et al
free

10.4244/EIJV16I18A265 Apr 2, 2021
Reducing refractory angina
de Silva R and Cheng K
free

10.4244/EIJV17I7A94 Sep 20, 2021
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?
Foley M and Al-Lamee R
free
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved